À propos de ce podcast
The go-to CMC and biomanufacturing podcast for bioprocess development scientists and CMC leaders scaling biologics into regulatory-ready therapies with less trial and error. Practical, execution-focused, and strategic guidance on CMC development, tech transfer, scale-up, GMP readiness, CDMO partnerships, and manufacturing economics for biologics, cell and gene therapies, cultivated meat, and biomaterials. Hosted by Dr. David Brühlmann, CMC strategist, former Bioprocess Innovation Manager at…
293 épisodes · Levenswetenschappen
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
À propos de ce podcast
The go-to CMC and biomanufacturing podcast for bioprocess development scientists and CMC leaders scaling biologics into regulatory-ready therapies with less trial and error. Practical, execution-focused, and strategic guidance on CMC development, tech transfer, scale-up, GMP readiness, CDMO partnerships, and manufacturing economics for biologics, cell and gene therapies, cultivated meat, and biomaterials. Hosted by Dr. David Brühlmann, CMC strategist, former Bioprocess Innovation Manager at…
Épisodes récents
- 295: Neither Small Molecule nor Biologic: The Cyclodextrin Dimer CMC Challenge with Matthew O'Connor - Part 1avant-hier · 25 min
- 294: Is CFD Overkill for Your Scale-Up? Why It Belongs in Every Biotech Scientist's Toolkit with Christian Witz - Part 28 oct. · 22 min
- 293: Is CFD Overkill for Your Scale-Up? Why It Belongs in Every Biotech Scientist's Toolkit with Christian Witz - Part 16 oct. · 23 min
- 292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 21 oct. · 22 min
- 291: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 129 sept. · 31 min
- 290: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 224 sept. · 20 min
- 289: Batch-to-Batch Variability Is a Design Failure, Not the Norm with Sandra Núñez - Part 122 sept. · 19 min
- 288: Why the Cell Line Is the CMC Decision You Don't Get to Undo with Sigma Mostafa - Part 217 sept. · 22 min
- 287: Why the Cell Line Is the CMC Decision You Don't Get to Undo with Sigma Mostafa - Part 115 sept. · 18 min
- 286: Why Your Dormant Omics Data Is Worth More Than the Data You'll Generate Next with Nathan Lewis - Part 210 sept. · 18 min
podlinkr.com/fr/smart-biotech-scientist-the-cmc-and-bioprocessin
Pour une affiche ou une diapo.